Simplex Trading
VRCA icon

Simplex Trading’s Verrica Pharmaceuticals VRCA Stock Holding History

Simplex Trading’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-490
Closed -$35K – 9686
2024
Q2 		$35K Sell
490
-20
-4% -$1.54K ﹤0.01% 6424
2024
Q1 		$30K Sell
510
-370
-42% -$20.4K ﹤0.01% 6766
2023
Q4 		$64K Sell
880
-130
-13% -$5.34K ﹤0.01% 5852
2023
Q3 		$39K Buy
1,010
+350
+53% +$17.8K ﹤0.01% 6038
2023
Q2 		$38K Sell
660
-350
-35% -$21.3K ﹤0.01% 6114
2023
Q1 		$65K Sell
1,010
-100
-9% -$6.05K ﹤0.01% 5638
2022
Q4 		$30K Sell
1,110
-160
-13% -$4.27K ﹤0.01% 6482
2022
Q3 		$37K Buy
1,270
+880
+226% +$30.1K ﹤0.01% 6829
2022
Q2 		$7K Buy
+390
New +$19.6K ﹤0.01% 8637
2022
Q1 		– Sell
-40
Closed -$3K – 11485
2021
Q4 		$3K Buy
40
+20
+100% +$2.27K ﹤0.01% 9887
2021
Q3 		$2K Hold
20
– – ﹤0.01% 9573
2021
Q2 		$2K Buy
+20
New +$2.42K ﹤0.01% 9753

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's VRCA Position: Q2 2025 in Review

Simplex Trading sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 156 shares.

Simplex Trading first reported a position in VRCA in Q2 2021 and held it in 12 quarters. The position peaked at $36K in Q3 2023. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Simplex Trading reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 156 Verrica Pharmaceuticals shares in Q2 2025.
  • Simplex Trading first reported a position in Verrica Pharmaceuticals in Q2 2021 and held it in 12 quarters.
  • Simplex Trading's Verrica Pharmaceuticals position peaked at $36K in Q3 2023.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.